Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Immunotherapy
"Hybrid Cell Vaccination in Cancer Immunotherapy: Recruitment and Activation of T Cell Help for Induction of Anti Tumour Cytotoxic T Cells."
November 24th, 1997
According to an abstract submitted by the author to the 3rd European Conference on Gene Therapy of Cancer, held September 11-13, 1997, in Berlin, Germany, "A new approach to cancer immunotherapy has been designed that takes into account the regulatory requirements for the induction of cytotoxic T cells. Help required for activation of precursor CTL and stimulation of effector CTL is, under physiological conditions, provided by helper T cells and, thus, depending on T-T cell collaboration in addition to the interaction of both cells with antigen presenting cells. Initial studies on the prerequisite and mechanism of this cell collaboration has revealed an epitope linkage requirement...
Source: Cancer Weekly (1997-11-24)
|
|
Advertisement |
|
|
